I have comprehensive real-time data. Let me now give you the complete BEL analysis.
📊 Bharat Electronics Limited (BEL) - Complete Fundamental Analysis
As of July 27, 2026 | CMP: ~₹405-407
🔴 Why the Stock Has Been Negative (Past 1-1.5 Years)
This is the most important thing to understand before deciding to invest:
| Period | Return |
|---|
| Past 1 week | -0.87% |
| Past 1 month | -4.99% |
| Past 3 months | -9.35% |
| Past 6 months | -2.53% |
| Past 1 year | ~+0.91% (nearly flat/negative) |
| Past 3 years | +225.53% |
| Past 5 years | +561.38% |
The reason is NOT fundamental deterioration. BEL ran from ~₹80 in 2020 to a peak of ~₹340-350 in early 2024, then corrected. The stock got severely overvalued at 50-60x P/E during the defense PSU frenzy of 2023-24. The past 18 months have been a valuation normalization, not a business problem.
✅ Key Fundamental Data (FY2026 - Latest Full Year)
| Metric | Value |
|---|
| Revenue (FY26) | ₹27,480 crore (+16% YoY) |
| PAT (FY26) | ₹6,048 crore (+14% YoY) |
| Q4 FY26 Revenue | ₹10,177 crore (+11.6% YoY) |
| Q4 FY26 Net Profit | ₹2,203 crore (+5% YoY) |
| EBITDA Margin | ~27-28% (strong) |
| Order Book (Opening FY27) | ₹73,000 crore |
| FY26 Order Inflows | ₹30,000 crore (incl. $346M exports) |
| Export Revenue Growth | +34% YoY |
| Dividend | ₹1.95/share declared (Feb 2026) |
| Market Cap | ~₹2,99,737 crore |
| EPS (FY26) | ~₹8.16 |
Management Guidance for FY27:
- Revenue growth: >15% YoY
- EBITDA margin: >28%
- Backed by robust ₹73,000 crore order book
📐 Valuation (Current)
| Metric | Value |
|---|
| CMP | ₹405-410 |
| P/E (FY26 EPS ~₹8.16) | ~50x |
| Sector P/E | 22.86x |
| P/B | ~6x (Sector P/B: 6.10x) |
| Div Yield | ~0.5-1% |
At ~50x P/E, BEL still trades at a premium to the sector. This is the key risk - the valuation is priced for perfection. However, given its execution track record, order book, and government backing, some premium is justified.
🎯 Price Targets - Dec 2026 & End of 2027
Analyst Consensus (25 analysts tracked):
| Scenario | Target Price |
|---|
| Low estimate | ₹349-350 |
| Average (consensus) | ₹460-498 |
| High estimate | ₹614 |
| Prabhudas Lilladher | ₹453 (Accumulate rating) |
My Estimated Projections:
By December 2026 (6 months from now):
- Base case: ₹450-480 - If FY27 execution stays on track (>15% revenue growth), re-rating likely
- Bull case: ₹520-550 - New large orders (QRSAM, Akash-NG, corvettes), defense budget boost
- Bear case: ₹360-380 - Order delays, margin compression, broader market selloff
By End of 2027 (18 months from now):
- Base case: ₹500-560 - FY27 PAT ~₹6,900-7,200 crore at 15% growth, at 45x P/E
- Bull case: ₹620-650 - Strong export momentum, new product wins, re-rating to 50x
- Bear case: ₹380-400 - Execution disappointments, defense spending cuts
These projections are built on:
- FY27E EPS: ~₹9.50-9.70 (per analyst estimates)
- FY27E Revenue: ₹31,500+ crore (per consensus)
- P/E range: 45-55x (defense PSU premium maintained)
💡 Should You Invest? (Honest Assessment)
✅ Strong BUY Arguments:
- ₹73,000 crore order book = ~2.7x annual revenue - multi-year visibility locked in
- Government of India owns 51.14% - virtually zero bankruptcy/existential risk
- Defense indigenization (Atmanirbhar Bharat) - structural, decade-long tailwind
- Export diversification - export orders growing 34% YoY, reducing India-only dependency
- 15%+ revenue growth guidance reaffirmed by management for FY27
- Navratna status - operational flexibility, can bid globally
- Upcoming catalysts: QRSAM, Uttam radars, next-gen corvettes, Shatrughat EW, AMCA
⚠️ Risks to Monitor:
- Still trades at 50x P/E - expensive vs. sector average of 22x
- Semiconductor import dependence - any global chip shortage could hurt margins
- Working capital deterioration - weak cash conversion is a concern flagged by analysts
- Execution lumpiness - revenue is Q4-heavy, quarters 1-3 often disappoint
- Defense budget allocation delays - government capex timing can shift revenues
📌 Final Verdict
Yes, hold/invest for a 18-24 month horizon. Here's why:
- The past 1.5 years of flat/negative returns are valuation digestion, not business decay
- Business fundamentals are the best they've ever been - 16% revenue growth, 14% PAT growth
- At ₹405-410, the stock has corrected ~25-30% from its peak - much of the froth is out
- The ₹73,000 crore order book gives you genuine earnings visibility
- Analyst average target of ₹460-498 implies 12-23% upside from current levels
- By end-2027, base case of ₹500-560 is realistic (~25-38% upside from CMP)
If you're buying for fundamentals with a 2-year view, this is a reasonable entry point around ₹400-410. Use dips toward ₹380-390 to add more aggressively.
⚠️ Disclaimer: This is purely an educational analysis based on publicly available data. I am not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making investment decisions. Stock markets carry risk and past performance is not a guarantee of future returns.